AVEO Pharmaceuticals

AVEO Pharmaceuticals

AVEO Pharmaceuticals

AVEO is a biopharmaceutical company focused on the discovery and development oftargeted cancer therapeutics.
Founded
2012
Raised
$120.7M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$25,000,000
Venture capital - 2010
Hercules Technology Growth Capital
$53,000,000
Venture capital (Series D) - 2007
Venrock
Team Size
10+
Employees
Pulse 2.0

AVEO Pharmaceuticals (AVEO) Stock: $14 Price Target And Buy Rating